Human UDP-Glucose 4-Epimerase (GALE) Protein

Product Graph
338€ (10 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Human UDP-Glucose 4-Epimerase (GALE) Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx692907
tested applications
SDS-PAGE

Description

Human UDP-Glucose 4-Epimerase Protein is a recombinant protein from Human produced in E. coli. Recombinant Human UDP-Glucose 4-Epimerase is produced by our E.coli expression system and the target gene encoding Met1-Ala348 is expressed with a 6His tag at the N-terminus.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
UDP-Glucose 4-Epimerase
Host
E. coli
Origin
Human
Observed MW
Molecular Weight: 40.4 kDa

Sequence Fragment: Met1-Ala348

Tag: N-terminal 6 His tag

Validity: The validity for this protein is 6 months.
Expression
Recombinant
Purity
> 95% (SDS-PAGE)
Size 1
10 µg
Size 2
50 µg
Tested Applications
SDS-PAGE
Buffer
50mM TrisHCl, 150mM NaCl, 2mM DTT, 1mM EDTA, pH 8.0.
Availability
Shipped within 5-15 working days.
Storage
Aliquot and store at < -20 °C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q14376
Background
Protein GALE
Status
RUO
Note
This product is for research use only.   Not for human consumption, cosmetic, therapeutic or diagnostic use.

Descripción

Related Products

FNab03309

GALE antibody

This gene encodes UDP-galactose-4-epimerase which catalyzes two distinct but analogous reactions: the epimerization of UDP-glucose to UDP-galactose, and the epimerization of UDP-N-acetylglucosamine to UDP-N-acetylgalactosamine. The bifunctional nature of the enzyme has the important metabolic consequence that mutant cells (or individuals) are dependent not only on exogenous galactose, but also on exogenous N-acetylgalactosamine as a necessary precursor for the synthesis of glycoproteins and glycolipids. Mutations in this gene result in epimerase-deficiency galactosemia, also referred to as galactosemia type 3, a disease characterized by liver damage, early-onset cataracts, deafness and mental retardation, with symptoms ranging from mild (&apos;peripheral&apos; form) to severe (&apos;generalized&apos; form). Multiple alternatively spliced transcripts encoding the same protein have been identified.

Ver Producto
P5787

Recombinant Human GALE

Ver Producto
abx005057

UDP-Glucose 4-Epimerase (GALE) Antibody

GALE Antibody is a Rabbit Polyclonal antibody against GALE. This gene encodes UDP-galactose-4-epimerase which catalyzes two distinct but analogous reactions: the epimerization of UDP-glucose to UDP-galactose, and the epimerization of UDP-N-acetylglucosamine to UDP-N-acetylgalactosamine. The bifunctional nature of the enzyme has the important metabolic consequence that mutant cells (or individuals) are dependent not only on exogenous galactose, but also on exogenous N-acetylgalactosamine as a necessary precursor for the synthesis of glycoproteins and glycolipids. Mutations in this gene result in epimerase-deficiency galactosemia, also referred to as galactosemia type 3, a disease characterized by liver damage, early-onset cataracts, deafness and mental retardation, with symptoms ranging from mild ('peripheral' form) to severe ('generalized' form). Multiple alternatively spliced transcripts encoding the same protein have been identified.

Ver Producto